Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und ohne ARDS
Michael Dreher, Dirk Müller‐Wieland(Universitätsklinikum Aachen), Alexander Kersten, Tobias Müller(Heidelberg University), Sebastian Lemmen(Universitätsklinikum Aachen), Johannes Bickenbach(RWTH Aachen University), Bojan Hartmann(Universitätsklinikum Aachen), Paul Balfanz(RWTH Aachen University), Gernot Marx(RWTH Aachen University), Jörg Christian Brokmann, Christian Cornélissen(RWTH Aachen University), Ayham Daher(RWTH Aachen University), Michael Kleines(RWTH Aachen University), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Nikolaus Marx(RWTH Aachen University)
RWTH Publications (RWTH Aachen)
January 1, 2020
Cited by 36
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
|The Lancet Respiratory Medicine|2020|864